Recommendations for diagnosis and treatment of systemic sclerosis in China
10.3760/cma.j.cn112138-20211227-00915
- VernacularTitle:系统性硬化病诊疗规范
- Author:
Hejian ZOU
1
;
Xiaoxia ZHU
;
Shengming DAI
;
Xiaobing WANG
;
Dongbao ZHAO
;
Yan ZHAO
Author Information
1. 复旦大学附属华山医院风湿免疫科，上海 200040
- Keywords:
Systemic sclerosis;
Diagnosis;
Treatment
- From:
Chinese Journal of Internal Medicine
2022;61(8):874-882
- CountryChina
- Language:Chinese
-
Abstract:
Systemic sclerosis (SSc) is an autoimmune rheumatic disease that is characterized by skin fibrosis with multi-organ involvement. In China, the standardized diagnosis and treatment for SSc is still lacking. Based on the diagnosis criteria and guidelines from China and abroad, Chinese Rheumatology Association developed the current standardization of diagnosis and treatment for SSc. The purposes of this guideline are to standardize clinical management for SSc in China, to interpret the key evaluation tools for SSc, and to recommend therapeutic principle and strategies.
